Remove 2013 Remove 2015 Remove Clinical Trials Remove Extraction
article thumbnail

Best strains and terpenes for pain management

The Cannigma

There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. A 2015 study of 279 Israeli cancer patients found that 70% of participants reported a reduction in pain and improvement in quality of life, 60% reported an increase in appetite and 50% reported a reduction in nausea.

Terpenes 111
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Researchers in Israel, Sweden, Estonia, and the USA have investigated media discourses about medicinal cannabis (Sznitman and Lewis 2015 ; Lewis et al. 2015 ; Kaiser 2011 ; Mortensen et al. No negative articles appear in these medical publications until 2015. MJA, 16 December 2013). 29) and negative ( n ?=?26)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NO BRAINER: CBD AND THC FOR HEAD INJURIES

Green Relief

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. In 2013, the International Journal of Molecular Science reported on how TBI is affected by diurnal variations of the endocannabinoid system. But CB1 proved to be a tricky target.

THC 64
article thumbnail

Green Relief - Untitled Article

Green Relief

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. In 2013, the International Journal of Molecular Science reported on how TBI is affected by diurnal variations of the endocannabinoid system. But CB1 proved to be a tricky target.

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.

article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

Safety is imperative for any reputable brand of hemp extract, and we are confident that the dosing we recommend is both safe and effective,” said Dr. Wakshlag, Chief Medical Officer at ElleVet Sciences. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement. Wakshlag, DVM, Ph.D.,

Safety 45